Journal of Immunology

Index Medicus: J Immunol # of Articles: 7

Articles

Cutting edge: p21-activated kinase (PAK) is required for fas-induced JNK activation in Jurkat Cells
  Rudel T, Zenke FT, Chuang T-H, and Bokoch GM
  Yr:1998 Vol:160 Nbr: Pgs: 7-11
  Associated Grant: The Role of PAK2 in Breast Cancer Cell Death
     
A B7.1-antibody fusion protein retains antibody specificity and ability to activate via the T cell costimulatory pathway
  Challita-Eid PM, Penichet ML, Shin S-U, Poles T, Mosammaparast N, and Morrison SL
  Yr:1998 Vol:160 Nbr: Pgs: 3419-3426
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
     
Immunohistochmical analysis of in vivo patterns ofTRAF-3 expression, a member of the TNF receptor-associated factor family
  Krajewski S, Zapata JM, Krajewska M, VanArsdale T,Shabaik A, Gascoyne RD, and Reed JC
  Yr:1997 Vol:159 Nbr: Pgs: 5841-5852
  Associated Grant: TRAF-regulated Signal Transduction in Breast Cancer
     
Immunohistochemical analysis of in vivo patterns of TRAF-3 expression, a member of the TNF receptor-associated factor family
  Krajewski S, Zapata JM, Krajewksa M, VanArsdale T,Shabaik A, and Reed JC, et al
  Yr:1997 Vol:159 Nbr: Pgs: 5841-5852
  Associated Grant: Immune responses to breast cancers: function of TRAF protein
     
Redirecting effectors T cells through thier IL-2 receptors
  Lustgarten, J., Marks, J., and Sherman, L.A.
  Yr:1999 Vol:162 Nbr:1 Pgs: 359-65
  Associated Grant: Antibody-IL-2 Fusion Protein for Breast Cancer Immunotherapy
     
A single-chain IL-12 IgG3 antibody fusion protein retains antibody specificity and IL-12 bioactivity and demonstrates antitumor activity
  Peng LS, Penichet ML, Morrison SL
  Yr:1999 Vol:163 Nbr:1 Pgs: 250-8
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer
     
A RANTES-antibody fusion protein retains antigen specificity and chemokine function.
  Challita-Eid PM, Abboud CN, Morrison SL, Penichet ML, Rosell KE, Poles T, Hilchey, et al.
  Yr:1998 Vol:161 Nbr:7 Pgs: 3729-36
  Associated Grant: Antibody Fusion Proteins for the Therapy of Breast Cancer